---
title: "葛兰素史克首席执行官表示，就药品定价问题正与美国政府进行非常有建设性的沟通，但拒绝就具体情况置评。"
description: "葛兰素史克首席执行官表示，就药品定价问题正与美国政府进行非常有建设性的沟通，但拒绝就具体情况置评。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263253947.md"
published_at: "2025-10-29T09:44:17.000Z"
---

# 葛兰素史克首席执行官表示，就药品定价问题正与美国政府进行非常有建设性的沟通，但拒绝就具体情况置评。

葛兰素史克首席执行官表示，就药品定价问题正与美国政府进行非常有建设性的沟通，但拒绝就具体情况置评。

### Related Stocks

- [GSK.US - 葛兰素史克](https://longbridge.com/zh-CN/quote/GSK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| GSK Begins Up to GBP450 Million Share Buyback Tranche | GSK Begins Up to GBP450 Million Share Buyback Tranche | [Link](https://longbridge.com/zh-CN/news/276103252.md) |
| Exdensur approved in EU for severe asthma and CRSwNP | GSK has received European Commission approval for Exdensur (depemokimab), the first ultra-long-acting biologic for sever | [Link](https://longbridge.com/zh-CN/news/276226507.md) |
| GSK's Exdensur Approved in EU as Add-on Treatment for Severe Asthma, Chronic Rhinosinusitis | GSK's Exdensur Approved in EU as Add-on Treatment for Severe Asthma, Chronic Rhinosinusitis | [Link](https://longbridge.com/zh-CN/news/276103226.md) |
| GSK Recieves Approval For Exdensur From The European Commission | GSK plc :GSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSIONGSK PLC - EXDENSUR APPROVED BY THE EUROPEAN COMMISSION | [Link](https://longbridge.com/zh-CN/news/276102835.md) |
| Berenberg Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK) | Berenberg Bank analyst Kerry Holford has maintained a Hold rating on GlaxoSmithKline (GSK) with a price target of £20.00 | [Link](https://longbridge.com/zh-CN/news/276103203.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。